https://doi.org/10.1155/2016/6354261
J
Jinny Park
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
302
Papers
4.7K
Citations
36
h-index
96
i10-index
Jinny Park is an academic researcher from Gachon University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 36, co-authored 257 publications.
ORCID: 0009-0005-3186-3591Papers by this author
worksSkin Aging‐Dependent Activation of the PI3K Signaling Pathway via Downregulation of PTEN Increases Intracellular ROS in Human Dermal Fibroblasts
2016 · Oxidative Medicine and Cellular Longevity · 51 citations
Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients
2015 · Leukemia & lymphoma/Leukemia and lymphoma · 34 citations
https://doi.org/10.3109/10428194.2015.1049166
Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial
2020 · Annals of Oncology · 25 citations
https://doi.org/10.1016/j.annonc.2020.12.009
Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
2004 · British Journal of Cancer · 24 citations
https://doi.org/10.1038/sj.bjc.6601891
Fisetin Inhibits UVA-Induced Expression of MMP-1 and MMP-3 through the NOX/ROS/MAPK Pathway in Human Dermal Fibroblasts and Human Epidermal Keratinocytes
2023 · International Journal of Molecular Sciences · 19 citations
https://doi.org/10.3390/ijms242417358
Relapsed or refractory nongastric marginal zone B‐cell lymphoma: Multicenter retrospective analysis of 92 cases
2009 · American Journal of Hematology · 12 citations
https://doi.org/10.1002/ajh.21557
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat